Tinnakorn Chaiworapongsa Selected Research

Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)

1/2022	Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
1/2015	Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
1/2014	In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
4/2013	Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
10/2011	Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.
8/2010	Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.
11/2009	A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.
1/2008	Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age.
1/2008	The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.
1/2008	A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tinnakorn Chaiworapongsa Research Topics

Disease

63	Inflammation (Inflammations) 12/2022 - 06/2002
54	Infections 12/2022 - 06/2002
46	Pre-Eclampsia (Preeclampsia) 01/2022 - 10/2002
43	Premature Obstetric Labor (Premature Labor) 12/2020 - 08/2002
34	Chorioamnionitis 12/2022 - 01/2002
20	Rupture 12/2020 - 01/2002
17	Fetal Death 07/2019 - 01/2005
12	Pyelonephritis 07/2019 - 04/2005
10	Preterm Premature Rupture of the Membranes 12/2020 - 08/2005
10	Premature Birth (Birth, Premature) 04/2014 - 01/2002
9	fetal inflammatory response syndrome 01/2016 - 06/2002
6	Overweight 03/2010 - 01/2009
6	Insulin Resistance 02/2010 - 12/2008
5	Hypertension (High Blood Pressure) 01/2022 - 10/2002
5	Fetal Growth Retardation (Intrauterine Growth Retardation) 03/2016 - 10/2002
5	Birth Weight (Birth Weights) 07/2013 - 01/2009
5	Sepsis (Septicemia) 12/2011 - 04/2005
5	Obesity 01/2010 - 12/2008
4	Infarction (Infarctions) 03/2016 - 04/2013
4	Pregnancy Complications 01/2016 - 08/2009
4	Hypoxia (Hypoxemia) 07/2015 - 02/2011
4	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2013 - 01/2009
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 01/2005
3	Bacterial Infections (Bacterial Infection) 01/2016 - 12/2005
3	Proteinuria 08/2014 - 07/2013
3	Endotoxemia 12/2011 - 12/2005
2	Pathologic Processes 12/2022 - 01/2017
2	Fever (Fevers) 01/2016 - 01/2016
2	Necrosis 01/2015 - 04/2003
2	Bacteremia 01/2015 - 11/2014
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2014 - 01/2013
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 07/2012 - 05/2010

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
20	CytokinesIBA 06/2022 - 06/2002
19	Interleukin-6 (Interleukin 6)IBA 01/2017 - 06/2002
17	InterleukinsIBA 07/2019 - 09/2008
14	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 07/2007
13	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2022 - 06/2004
13	AdipokinesIBA 05/2010 - 12/2008
11	Biomarkers (Surrogate Marker)IBA 12/2022 - 12/2010
11	EndoglinIBA 01/2022 - 01/2008
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 06/2004
9	Messenger RNA (mRNA)IBA 11/2021 - 10/2002
9	Complement System Proteins (Complement)IBA 01/2018 - 01/2005
9	ChemokinesIBA 10/2017 - 06/2005
8	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 01/2008
8	Nicotinamide PhosphoribosyltransferaseIBA 10/2010 - 01/2008
7	Thrombin FDA Link 07/2018 - 10/2008
7	Biological ProductsIBA 01/2016 - 01/2009
6	N 30IBA 09/2013 - 07/2008
6	AdiponectinIBA 02/2010 - 01/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2002
5	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2009
5	Thromboplastin (Tissue Factor)IBA 06/2018 - 10/2008
5	EnzymesIBA 01/2016 - 11/2002
5	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2015 - 07/2005
5	AntibodiesIBA 12/2011 - 09/2008
5	AnaphylatoxinsIBA 07/2010 - 01/2005
4	ProteomeIBA 12/2022 - 03/2011
4	lipoprotein-associated coagulation inhibitor (TFPI)IBA 06/2018 - 10/2008
4	FibrinIBA 03/2016 - 04/2013
4	Interferon-gamma (Interferon, gamma)IBA 01/2016 - 06/2012
4	EndotoxinsIBA 07/2014 - 02/2013
4	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 02/2010 - 01/2010
3	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 11/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2010
3	InflammasomesIBA 10/2017 - 09/2008
3	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 01/2016
3	HMGB1 Protein (HMG1)IBA 11/2014 - 12/2011
3	Progesterone FDA LinkGeneric 02/2014 - 01/2013
3	AntigensIBA 01/2014 - 10/2008
3	Interleukin-10 (Interleukin 10)IBA 09/2013 - 08/2008
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2011 - 12/2009
3	Hemostatics (Antihemorrhagics)IBA 11/2009 - 10/2008
3	plasma protein Z (protein Z)IBA 08/2009 - 09/2007
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2019
2	Fibronectins (Fibronectin)IBA 11/2021 - 09/2012
2	DefensinsIBA 12/2020 - 10/2018
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2019 - 01/2017
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 10/2017 - 01/2017
2	CaspasesIBA 10/2017 - 10/2004
2	Pravastatin (Pravachol)FDA LinkGeneric 01/2017 - 03/2016
2	LipidsIBA 10/2016 - 01/2015
2	Interleukin-8 (Interleukin 8)IBA 01/2016 - 04/2003
2	ImmunosorbentsIBA 01/2016 - 01/2016
2	Interleukin-4 (Interleukin 4)IBA 01/2016 - 12/2015
2	Interleukin-33IBA 12/2015 - 09/2013
2	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 05/2014 - 05/2010
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2014 - 11/2010
2	RNA (Ribonucleic Acid)IBA 10/2013 - 10/2004
2	AlarminsIBA 06/2012 - 12/2011
2	Immunoglobulin G (IgG)IBA 12/2011 - 08/2009
2	Immunoglobulin M (IgM)IBA 12/2011 - 08/2009
2	Hemoglobins (Hemoglobin)IBA 09/2011 - 05/2009
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2011 - 11/2010

Therapy/Procedure

3	Artificial Respiration (Mechanical Ventilation) 11/2014 - 01/2013
3	Cervical Cerclage 02/2014 - 01/2013
2	Surgical Instruments (Clip) 12/2022 - 09/2012